Therapeutic Solutions International (TSOI) Stock Price, News & Analysis

Company Overview

Therapeutic Solutions International, Inc. is a biotechnology company focused on developing immunotherapies and regenerative medicine products. The company’s work is centered on treatments designed to regulate the immune system and support tissue repair, with research programs addressing areas such as cancer, infectious diseases, inflammation and other serious medical conditions.

Its reported product and development portfolio has included cell-based therapies such as JadiCell, immune-modulating programs such as StemVacs, and nutraceutical products including QuadraMune. The company has also described research involving small-molecule and plant-derived compounds, including NanoStilbene. The availability and development status of these programs may vary, and many remain investigational rather than approved medical treatments.

Therapeutic Solutions International is based in the United States and has conducted research and development activities through collaborations with scientists, physicians and academic or clinical partners. Timothy Dixon has served as the company’s president and chief executive officer. The company’s programs are subject to ongoing research, clinical evaluation and regulatory review.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1,277 shs
• Average Volume: 20.24 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:TSOI
• CIK: 1419051
• Web: therapeuticsolutionsint.com
• Phone: (760) 295-7208
• Fax: N/A
• Employees: 3
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A